Illumina reagents and consumables
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N92020D00022
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1,051 $85,570,362 obligated
Award facts
- Opportunity
-
- 75N92020Q0039 Solicitation number
- Illumina Reagents and Consumables Pre-Solicitation · Posted Jan 23, 2020
- Combined order value
-
- $85,606,116 Current, with exercised options
- $88,985,335 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 93% used
- $92,416,478.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, has been awarded a single-award Indefinite Delivery Contract (IDC) by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH). The IDC has a ceiling value of $92,416,478 and a period of performance through March 2, 2026.
Under this IDC and associated delivery orders, Illumina will provide a range of its advanced sequencing instruments, including NextSeq, NovaSeq, MiSeq, and iSeq systems, along with reagents, consumables, maintenance services, and bioinformatics software to support genomic research and diagnostic initiatives across multiple NIH institutes and centers, as well as other federal agencies such as the Centers for Disease Control and Prevention (CDC), Department of Agriculture (USDA), Department of Veterans Affairs (VA), and Food and Drug Administration (FDA). The contract does not utilize any set-aside designations, reflecting Illumina's status as a specialized technology provider. The place of performance is primarily at Illumina's facility in San Diego, California.
Task orders
Show 40 more
Latest 50 of 1,051 listed here. See the rest on GovTribe.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N92020D00022?
75N92020D00022 was awarded to Illumina, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 3, 2020.
How much is contract 75N92020D00022 worth?
Orders under 75N92020D00022 have obligated $85,570,362. Their combined current value, with exercised options, is $85,606,116. Their combined potential value, with all options, is $88,985,335. 75N92020D00022's own ceiling is $92,416,478.
How many orders have been placed under contract 75N92020D00022?
1,051 orders have been placed under 75N92020D00022, the latest on February 27, 2026.
Who can order from contract 75N92020D00022?
75N92020D00022 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N92020D00022 competed?
The extent of competition for 75N92020D00022 was not competed. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV